drugset / Trial / NCT04870164
Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)
RandomizedSequentialQuadruple-blindOther
Summary
This study will investigate how ensovibep is distributed throughout the body, the safety and the tolerability of ensovibep in healthy volunteers
Timeline
- Start
- 2020-11-18
- Primary completion
- 2022-01-06
- Completion
- 2022-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ensovibep | Protein / enzyme biologic | — | Intravenous |